As part of our ongoing aim to bring you reports of interesting new studies, we have added a review of a study titled: Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment.
Independent expert commentary is provided by Dr Scott Dunkley, a senior staff specialist haematologist at Royal Prince Alfred Hospital, Sydney and the Thrombosis and Pregnancy Clinic at Charles Perkins Centre, University of Sydney.
* Revised Copy September 2022
Please login below to download this issue (PDF)